The Fort Worth Press - Ketogenic Diet Delivers Largest Liver-Fat Reduction in Three-Diet Trial

USD -
AED 3.673042
AFN 65.000368
ALL 79.715041
AMD 364.320403
ANG 1.789783
AOA 917.000367
ARS 1499.143585
AUD 1.395504
AWG 1.8
AZN 1.70397
BAM 1.679281
BBD 2.014502
BDT 123.298316
BGN 1.696366
BHD 0.37703
BIF 2992
BMD 1
BND 1.271197
BOB 11.727937
BRL 5.193604
BSD 1.00021
BTN 95.349267
BWP 13.402252
BYN 3.016542
BYR 19600
BZD 2.011669
CAD 1.39105
CDF 2273.000362
CHF 0.809457
CLF 0.023655
CLP 931.010396
CNY 6.72675
CNH 6.731305
COP 3211.02
CRC 451.378305
CUC 1
CUP 26.5
CVE 95.503894
CZK 20.838504
DJF 177.720393
DKK 6.453404
DOP 58.750393
DZD 133.39204
EGP 49.798455
ERN 15
ETB 160.503874
EUR 0.863104
FJD 2.198804
FKP 0.737808
GBP 0.738825
GEL 2.603861
GGP 0.737808
GHS 11.19504
GIP 0.737808
GMD 74.000355
GNF 8780.000355
GTQ 7.634879
GYD 209.263688
HKD 7.84235
HNL 26.870388
HRK 6.505404
HTG 130.854201
HUF 315.250388
IDR 17757.4
ILS 2.976204
IMP 0.737808
INR 95.43455
IQD 1310.5
IRR 1374575.000352
ISK 121.390386
JEP 0.737808
JMD 158.543444
JOD 0.70904
JPY 160.07504
KES 129.440385
KGS 87.450384
KHR 4045.503796
KMF 425.00035
KPW 900.000294
KRW 1377.570383
KWD 0.30892
KYD 0.833552
KZT 463.527826
LAK 22425.000349
LBP 89550.000349
LKR 328.019886
LRD 180.250382
LSL 15.990381
LTL 2.95274
LVL 0.60489
LYD 6.340381
MAD 9.289039
MDL 17.293533
MGA 4329.000347
MKD 52.82251
MMK 2099.727459
MNT 3597.739732
MOP 8.07707
MRU 40.110379
MUR 46.840378
MVR 15.460378
MWK 1736.000345
MXN 17.034504
MYR 4.025904
MZN 63.910377
NAD 15.990377
NGN 1341.580377
NIO 36.720377
NOK 9.375804
NPR 152.558483
NZD 1.691475
OMR 0.381078
PAB 1.00021
PEN 3.351504
PGK 4.42225
PHP 62.270375
PKR 277.550374
PLN 3.74735
PYG 5927.077117
QAR 3.645038
RON 4.539504
RSD 101.324183
RUB 86.149411
RWF 1469
SAR 3.789762
SBD 8.000184
SCR 13.880372
SDG 601.503676
SEK 9.57835
SGD 1.274504
SHP 0.740866
SLE 24.625038
SLL 20969.499227
SOS 571.503662
SRD 37.74037
STD 20697.981008
STN 21.375
SVC 8.75176
SYP 13001.999906
SZL 15.990369
THB 33.150369
TJS 9.25201
TMT 3.51
TND 2.913038
TOP 2.40776
TRY 48.240368
TTD 6.788276
TWD 31.638704
TZS 2644.998038
UAH 44.565558
UGX 3771.073837
UYU 40.278022
UZS 11825.000334
VES 790.677104
VND 26085
VUV 118.250696
WST 2.707834
XAF 563.222427
XAG 0.015062
XAU 0.000224
XCD 2.70255
XCG 1.80268
XDR 0.707052
XOF 563.000332
XPF 103.503591
YER 236.525037
ZAR 16.17251
ZMK 9001.203584
ZMW 18.929211
ZWL 321.999592
  • BCE

    0.0600

    23.46

    +0.26%

  • CMSC

    -0.0200

    21.29

    -0.09%

  • JRI

    -0.0500

    12.35

    -0.4%

  • CMSD

    0.0000

    21.18

    0%

  • RELX

    0.2400

    36.54

    +0.66%

  • RBGPF

    0.0800

    70.77

    +0.11%

  • VOD

    0.1600

    16.04

    +1%

  • RYCEF

    -0.2500

    20.5

    -1.22%

  • AZN

    -1.8200

    162.7

    -1.12%

  • BCC

    -0.0200

    78.75

    -0.03%

  • BP

    -0.1900

    42.15

    -0.45%

  • RIO

    -1.4800

    103.3

    -1.43%

  • GSK

    0.5500

    50.82

    +1.08%

  • NGG

    -0.0800

    79.35

    -0.1%

  • BTI

    -0.1500

    56.13

    -0.27%

Ketogenic Diet Delivers Largest Liver-Fat Reduction in Three-Diet Trial
Ketogenic Diet Delivers Largest Liver-Fat Reduction in Three-Diet Trial

Ketogenic Diet Delivers Largest Liver-Fat Reduction in Three-Diet Trial

A controlled study found that ketogenic, Mediterranean and plant-forward diets all improved weight and blood-sugar measures, but the ketogenic plan produced the largest decline in liver fat.

Text size:

A clinical study comparing three widely used eating patterns found that all three helped participants lose weight and improve several metabolic measures, while a ketogenic diet produced the strongest improvement in liver fat.

The research examined ketogenic, Mediterranean and plant-forward diets, which differ sharply in the balance of carbohydrates and fat. Participants had obesity, pre-diabetes and fatty liver disease, and researchers randomly assigned each person to one of the plans. All meals were supplied by the research team.

Calorie intake was adjusted so that participants in every group lost about 10% of their body weight over four to five months. That design allowed investigators to compare the effects of diet composition while keeping the amount of weight loss broadly similar.

The ketogenic plan restricted carbohydrates to about 4% of calories and emphasized healthy fats, encouraging the body to rely more heavily on fat. The plant-forward plan took the opposite approach, with about 70% of calories coming from carbohydrates, little fat, a focus on whole plant foods and fewer animal products.

The Mediterranean plan occupied the middle ground. Roughly half of its calories came from carbohydrates, about one-third from fat and around one-fifth from protein.

Participants following each diet lost weight and body fat. All three groups also became more sensitive to insulin and improved their control of blood sugar. Reduced insulin sensitivity can, over time, contribute to the development of diabetes.

The clearest difference concerned fat stored in the liver. The ketogenic group recorded an average reduction of 67%, compared with 45% in both the Mediterranean and plant-forward groups.

Fatty liver disease can develop when excess body fat increases the release of fatty acids into the bloodstream and the liver absorbs them. The condition can progress to inflammation, tissue damage and scarring, and in severe cases to life-threatening cirrhosis.

Researchers said the ketogenic group had the largest rise in glucagon, a hormone that promotes the loss of liver fat. It also showed the largest reduction in blood insulin, another change associated with lowering liver fat.

Study author Max Petersen said an unexpected result was that people assigned to the ketogenic plan did not show an increase in blood fat or cholesterol even though they consumed the greatest proportion of fat. He said the results suggest diet changes may add benefits at a time when GLP-1 medicines are reshaping weight-loss treatment.

GLP-1 medicines such as Ozempic and Zepbound are generally recommended alongside changes in diet and other aspects of daily life. With an estimated 42% of Americans trying to lose weight, dietary choices remain an important part of managing weight and related health risks.

The ketogenic diet has also been used in epilepsy care and by endurance athletes and bodybuilders seeking to lose fat. Research has explored its use for some psychiatric conditions as well.

The plan nevertheless has limitations. Rapid early weight loss may partly reflect the loss of water rather than body fat, and the severe restriction of carbohydrates can make the diet difficult to sustain.

It can also leave some people short of nutrients or calories. Reported effects of the so-called keto flu include fatigue, irritability and mental fog. Other research has raised questions about possible links to heart disease and small-intestine cancer.

Because medical history and nutritional needs differ, the appropriate diet is an individual decision. People considering major dietary changes, particularly those with metabolic disease, were advised to consult a physician or dietitian.

P.Grant--TFWP